{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T11:39:48Z","timestamp":1794397188842,"version":"4.9.0"},"reference-count":136,"publisher":"Elsevier BV","issue":"9560","license":[{"start":{"date-parts":[[2007,2,1]],"date-time":"2007-02-01T00:00:00Z","timestamp":1170288000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2007,2,1]],"date-time":"2007-02-01T00:00:00Z","timestamp":1170288000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2007,2,1]],"date-time":"2007-02-01T00:00:00Z","timestamp":1170288000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2007,2,1]],"date-time":"2007-02-01T00:00:00Z","timestamp":1170288000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2007,2,1]],"date-time":"2007-02-01T00:00:00Z","timestamp":1170288000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2007,2,1]],"date-time":"2007-02-01T00:00:00Z","timestamp":1170288000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2007,2,1]],"date-time":"2007-02-01T00:00:00Z","timestamp":1170288000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet"],"published-print":{"date-parts":[[2007,2]]},"DOI":"10.1016\/s0140-6736(07)60237-2","type":"journal-article","created":{"date-parts":[[2007,2,10]],"date-time":"2007-02-10T07:11:43Z","timestamp":1171091503000},"page":"499-511","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":650,"title":["Narcolepsy with cataplexy"],"prefix":"10.1016","volume":"369","author":[{"given":"Yves","family":"Dauvilliers","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabelle","family":"Arnulf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emmanuel","family":"Mignot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/S0140-6736(07)60237-2_bib1","series-title":"The International Classification of Sleep Disorders: diagnostic and coding manual","author":"American Academy of Sleep Medicine","year":"2005"},{"key":"10.1016\/S0140-6736(07)60237-2_bib2","doi-asserted-by":"crossref","first-page":"2000","DOI":"10.1016\/S1388-2457(03)00203-7","article-title":"Clinical aspects and pathophysiology of narcolepsy","volume":"114","author":"Dauvilliers","year":"2003","journal-title":"Clin Neurophysio"},{"key":"10.1016\/S0140-6736(07)60237-2_bib3","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1097\/00004691-200103000-00002","article-title":"Narcolepsy: clinical features, new pathophysiologic insights, and future perspectives","volume":"18","author":"Overeem","year":"2001","journal-title":"J Clin Neurophysiol"},{"key":"10.1016\/S0140-6736(07)60237-2_bib4","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1002\/ana.10444","article-title":"The neurobiology, diagnosis, and treatment of narcolepsy","volume":"53","author":"Scammell","year":"2003","journal-title":"Ann Neurol"},{"key":"10.1016\/S0140-6736(07)60237-2_bib5","first-page":"631","article-title":"Eigent\u00fcmliche mit Einschlafen verbundene Anf\u00e4lle","volume":"7","author":"Westphal","year":"1877","journal-title":"Arch Psychiatr Nervenkr"},{"key":"10.1016\/S0140-6736(07)60237-2_bib6","first-page":"626","article-title":"De la narcolepsie","volume":"53","author":"G\u00e9lineau","year":"1880","journal-title":"Gazette des H\u00f4pitaux (Paris)"},{"key":"10.1016\/S0140-6736(07)60237-2_bib7","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1002\/ana.410350612","article-title":"The prevalence of narcolepsy: an epidemiological study of the Finnish Twin Cohort","volume":"35","author":"Hublin","year":"1994","journal-title":"Ann Neurol"},{"key":"10.1016\/S0140-6736(07)60237-2_bib8","doi-asserted-by":"crossref","first-page":"1826","DOI":"10.1212\/WNL.58.12.1826","article-title":"Prevalence of narcolepsy symptomatology and diagnosis in the European general population","volume":"58","author":"Ohayon","year":"2002","journal-title":"Neurology"},{"key":"10.1016\/S0140-6736(07)60237-2_bib9","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1002\/ana.10162","article-title":"The prevalence of narcolepsy among Chinese in Hong Kong","volume":"51","author":"Wing","year":"2002","journal-title":"Ann Neurol"},{"key":"10.1016\/S0140-6736(07)60237-2_bib10","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1093\/sleep\/25.2.197","article-title":"The epidemiology of narcolepsy in Olmsted County, Minnesota: a population-based study","volume":"25","author":"Silber","year":"2002","journal-title":"Sleep"},{"key":"10.1016\/S0140-6736(07)60237-2_bib11","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/S0092-8674(00)81965-0","article-title":"The sleep disorder canine narcolepsy is caused by a mutation in the hypocretin (orexin) receptor 2 gene","volume":"98","author":"Lin","year":"1999","journal-title":"Cell"},{"key":"10.1016\/S0140-6736(07)60237-2_bib12","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/S0092-8674(00)81973-X","article-title":"Narcolepsy in orexin knockout mice: molecular genetics of sleep regulation","volume":"98","author":"Chemelli","year":"1999","journal-title":"Cell"},{"key":"10.1016\/S0140-6736(07)60237-2_bib13","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1001\/archneur.59.10.1553","article-title":"The role of cerebrospinal fluid hypocretin measurement in the diagnosis of narcolepsy and other hypersomnias","volume":"59","author":"Mignot","year":"2002","journal-title":"Arch Neurol"},{"key":"10.1016\/S0140-6736(07)60237-2_bib14","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1038\/79690","article-title":"A mutation in a case of early onset narcolepsy and a generalized absence of hypocretin peptides in human narcoleptic brains","volume":"6","author":"Peyron","year":"2000","journal-title":"Nat Med"},{"key":"10.1016\/S0140-6736(07)60237-2_bib15","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/S0896-6273(00)00058-1","article-title":"Reduced number of hypocretin neurons in human narcolepsy","volume":"27","author":"Thannickal","year":"2000","journal-title":"Neuron"},{"key":"10.1016\/S0140-6736(07)60237-2_bib16","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1212\/01.WNL.0000168173.71940.ab","article-title":"Concomitant loss of dynorphin, NARP, and orexin in narcolepsy","volume":"65","author":"Crocker","year":"2005","journal-title":"Neurology"},{"key":"10.1016\/S0140-6736(07)60237-2_bib17","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1212\/01.wnl.0000175219.01544.c8","article-title":"Narp immunostaining of human hypocretin (orexin) neurons: loss in narcolepsy","volume":"65","author":"Blouin","year":"2005","journal-title":"Neurology"},{"key":"10.1016\/S0140-6736(07)60237-2_bib18","first-page":"147","article-title":"The prevalence of narcolepsy II","volume":"2","author":"Dement","year":"1973","journal-title":"Sleep Res"},{"key":"10.1016\/S0140-6736(07)60237-2_bib19","first-page":"191","article-title":"Census of narcolepsy, cataplexy and sleep life among teenagers in Fujisawa city","volume":"8","author":"Honda","year":"1979","journal-title":"Sleep Res"},{"key":"10.1016\/S0140-6736(07)60237-2_bib20","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1093\/sleep\/10.6.608","article-title":"Narcolepsy is a rare disease in Israel","volume":"10","author":"Lavie","year":"1987","journal-title":"Sleep"},{"key":"10.1016\/S0140-6736(07)60237-2_bib21","doi-asserted-by":"crossref","first-page":"2029","DOI":"10.1212\/WNL.57.11.2029","article-title":"Age at onset of narcolepsy in two large populations of patients in France and Quebec","volume":"57","author":"Dauvilliers","year":"2001","journal-title":"Neurology"},{"issue":"suppl 8","key":"10.1016\/S0140-6736(07)60237-2_bib22","doi-asserted-by":"crossref","first-page":"S50","DOI":"10.1093\/sleep\/17.suppl_8.S50","article-title":"Life events in the year preceding the onset of narcolepsy","volume":"17","author":"Orellana","year":"1994","journal-title":"Sleep"},{"key":"10.1016\/S0140-6736(07)60237-2_bib23","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.sleep.2003.06.002","article-title":"Factors associated with a delay in the diagnosis of narcolepsy","volume":"5","author":"Morrish","year":"2004","journal-title":"Sleep Med"},{"key":"10.1016\/S0140-6736(07)60237-2_bib24","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1093\/sleep\/16.5.444","article-title":"Scheduled naps in the management of daytime sleepiness in narcolepsy-cataplexy","volume":"16","author":"Mullington","year":"1993","journal-title":"Sleep"},{"key":"10.1016\/S0140-6736(07)60237-2_bib25","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/S1389-9457(02)00005-9","article-title":"A comparison of sleep deprivation and narcolepsy in terms of complex cognitive performance and subjective sleepiness","volume":"3","author":"Hood","year":"2002","journal-title":"Sleep Med"},{"key":"10.1016\/S0140-6736(07)60237-2_bib26","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1093\/sleep\/9.1.194","article-title":"Alerting effects of naps in patients with narcolepsy","volume":"9","author":"Roehrs","year":"1986","journal-title":"Sleep"},{"key":"10.1016\/S0140-6736(07)60237-2_bib27","first-page":"77","article-title":"Validation of a cataplexy questionnaire in 983 sleep-disorders patients","volume":"22","author":"Anic-Labat","year":"1999","journal-title":"Sleep"},{"key":"10.1016\/S0140-6736(07)60237-2_bib28","doi-asserted-by":"crossref","first-page":"43","DOI":"10.2165\/00023210-200620010-00004","article-title":"Cataplexy associated with narcolepsy: epidemiology, pathophysiology and management","volume":"20","author":"Thorpy","year":"2006","journal-title":"CNS Drugs"},{"key":"10.1016\/S0140-6736(07)60237-2_bib29","series-title":"Narcolepsy","first-page":"125","article-title":"Cataplexy","author":"Guilleminault","year":"1976"},{"key":"10.1016\/S0140-6736(07)60237-2_bib30","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1111\/j.1365-2869.2004.00411.x","article-title":"Corticospinal excitability during laughter: implications for cataplexy and the comparison with REM sleep atonia","volume":"13","author":"Overeem","year":"2004","journal-title":"J Sleep Res"},{"key":"10.1016\/S0140-6736(07)60237-2_bib31","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1212\/01.wnl.0000175978.61048.62","article-title":"Unusually prolonged rebound cataplexy after withdrawal of fluoxetine","volume":"65","author":"Poryazova","year":"2005","journal-title":"Neurology"},{"key":"10.1016\/S0140-6736(07)60237-2_bib32","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/S0165-1781(00)00227-4","article-title":"Prevalence of hallucinations and their pathological associations in the general population","volume":"97","author":"Ohayon","year":"2000","journal-title":"Psychiatry Res"},{"key":"10.1016\/S0140-6736(07)60237-2_bib33","first-page":"245","article-title":"Physiology of REM sleep, cataplexy, and sleep paralysis","volume":"67","author":"Hishikawa","year":"1995","journal-title":"Adv Neurol"},{"key":"10.1016\/S0140-6736(07)60237-2_bib34","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1093\/sleep\/25.1.27","article-title":"Clinical aspects of narcolepsy-cataplexy across ethnic groups","volume":"25","author":"Okun","year":"2002","journal-title":"Sleep"},{"key":"10.1016\/S0140-6736(07)60237-2_bib35","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.sleep.2003.10.006","article-title":"A putative link between childhood narcolepsy and obesity","volume":"5","author":"Kotagal","year":"2004","journal-title":"Sleep Med"},{"key":"10.1016\/S0140-6736(07)60237-2_bib36","doi-asserted-by":"crossref","first-page":"2134","DOI":"10.1212\/WNL.43.10.2134","article-title":"Effects of bromocriptine on periodic limb movements in human narcolepsy","volume":"43","author":"Boivin","year":"1993","journal-title":"Neurology"},{"key":"10.1016\/S0140-6736(07)60237-2_bib37","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.sleep.2004.11.007","article-title":"The association between narcolepsy and REM behavior disorder (RBD)","volume":"6","author":"Nightingale","year":"2005","journal-title":"Sleep Med"},{"key":"10.1016\/S0140-6736(07)60237-2_bib38","first-page":"291","article-title":"Depresssion in narcolepsy and hypersommia","volume":"116","author":"Roth","year":"1975","journal-title":"Schweiz Arch Neurol Neurochir Psychiatr"},{"key":"10.1016\/S0140-6736(07)60237-2_bib39","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/S1389-9457(03)00059-5","article-title":"Sleep disorders and depressive feelings: a global survey with the Beck depression scale","volume":"4","author":"Vandeputte","year":"2003","journal-title":"Sleep Med"},{"key":"10.1016\/S0140-6736(07)60237-2_bib40","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1212\/01.WNL.0000101725.34089.1E","article-title":"Effect of age on MSLT results in patients with narcolepsy-cataplexy","volume":"62","author":"Dauvilliers","year":"2004","journal-title":"Neurology"},{"key":"10.1016\/S0140-6736(07)60237-2_bib41","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1046\/j.1365-2869.2001.00234.x","article-title":"Health-related quality of life in narcolepsy","volume":"10","author":"Daniels","year":"2001","journal-title":"J Sleep Res"},{"key":"10.1016\/S0140-6736(07)60237-2_bib42","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1017\/S0317167100043419","article-title":"Life effects of narcolepsy in 180 patients from North America, Asia and Europe compared to matched controls","volume":"8","author":"Broughton","year":"1981","journal-title":"Can J Neurol Sci"},{"key":"10.1016\/S0140-6736(07)60237-2_bib43","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1001\/archneur.1982.00510150039009","article-title":"Narcolepsy-cataplexy. II. Psychosocial consequences and associated psychopathology","volume":"39","author":"Kales","year":"1982","journal-title":"Arch Neurol"},{"key":"10.1016\/S0140-6736(07)60237-2_bib44","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1378\/chest.108.3.619","article-title":"Vigilance and automobile accidents in patients with sleep apnoea or narcolepsy","volume":"108","author":"Findley","year":"1995","journal-title":"Chest"},{"key":"10.1016\/S0140-6736(07)60237-2_bib45","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1093\/sleep\/22.6.757","article-title":"Health-related quality of life effects of modafinil for treatment of narcolepsy","volume":"22","author":"Beusterien","year":"1999","journal-title":"Sleep"},{"key":"10.1016\/S0140-6736(07)60237-2_bib46","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1093\/sleep\/9.4.519","article-title":"Guidelines for the Multiple Sleep Latency Test (MSLT): a standard measure of sleepiness","volume":"9","author":"Carskadon","year":"1986","journal-title":"Sleep"},{"key":"10.1016\/S0140-6736(07)60237-2_bib47","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/s1389-9457(02)00191-0","article-title":"The narcoleptic borderland: a multimodal diagnostic approach including cerebrospinal fluid levels of hypocretin-1 (orexin A)","volume":"4","author":"Bassetti","year":"2003","journal-title":"Sleep Med"},{"key":"10.1016\/S0140-6736(07)60237-2_bib48","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1007\/s11910-996-0039-2","article-title":"Differential diagnosis in hypersomnia","volume":"6","author":"Dauvilliers","year":"2006","journal-title":"Curr Opin Neurol Neurosciences"},{"key":"10.1016\/S0140-6736(07)60237-2_bib49","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1056\/NEJM199304293281704","article-title":"The occurrence of sleep-disordered breathing among middle-aged adults","volume":"328","author":"Young","year":"1993","journal-title":"N Engl J Med"},{"key":"10.1016\/S0140-6736(07)60237-2_bib50","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1136\/jnnp.74.12.1667","article-title":"CSF hypocretin-1 levels in narcolepsy, Kleine-Levin syndrome, and other hypersomnias and neurological conditions","volume":"74","author":"Dauvilliers","year":"2003","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/S0140-6736(07)60237-2_bib51","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1212\/01.wnl.0000186118.96509.94","article-title":"Narcolepsy: selective hypocretin (orexin) neuronal loss and multiple signaling deficiencies","volume":"65","author":"Bassetti","year":"2005","journal-title":"Neurology"},{"key":"10.1016\/S0140-6736(07)60237-2_bib52","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1053\/smrv.2001.0168","article-title":"Idiopathic Hypersomnia","volume":"5","author":"Billiard","year":"2001","journal-title":"Sleep Med Rev"},{"key":"10.1016\/S0140-6736(07)60237-2_bib53","doi-asserted-by":"crossref","first-page":"2763","DOI":"10.1093\/brain\/awh620","article-title":"Kleine-Levin syndrome: a systematic review of 186 cases in the literature","volume":"128","author":"Arnulf","year":"2005","journal-title":"Brain"},{"key":"10.1016\/S0140-6736(07)60237-2_bib54","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1097\/00006842-200003000-00013","article-title":"Differences in nocturnal and daytime sleep between primary and psychiatric hypersomnia: diagnostic and treatment implications","volume":"62","author":"Vgontzas","year":"2000","journal-title":"Psychosom Med"},{"key":"10.1016\/S0140-6736(07)60237-2_bib55","first-page":"159","article-title":"REM latency: a biological marker for primary depressive disease","volume":"11","author":"Kupfer","year":"1976","journal-title":"Biol Psychiatry"},{"key":"10.1016\/S0140-6736(07)60237-2_bib56","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.smrv.2005.03.004","article-title":"Symptomatic narcolepsy, cataplexy and hypersomnia, and their implications in the hypothalamic hypocretin\/orexin system","volume":"9","author":"Nishino","year":"2005","journal-title":"Sleep Med Rev"},{"key":"10.1016\/S0140-6736(07)60237-2_bib57","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1093\/sleep\/25.6.662","article-title":"Excessive daytime somnolence and increased rapid eye movement pressure in myotonic dystrophy","volume":"25","author":"Gibbs","year":"2002","journal-title":"Sleep"},{"key":"10.1016\/S0140-6736(07)60237-2_bib58","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1212\/WNL.58.7.1019","article-title":"Parkinson's disease and sleepiness: an integral part of PD","volume":"58","author":"Arnulf","year":"2002","journal-title":"Neurology"},{"key":"10.1016\/S0140-6736(07)60237-2_bib59","doi-asserted-by":"crossref","first-page":"3475","DOI":"10.1073\/pnas.88.8.3475","article-title":"Genetic linkage of autosomal recessive canine narcolepsy with a mu immunoglobulin heavy-chain switch-like segment","volume":"88","author":"Mignot","year":"1991","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/S0140-6736(07)60237-2_bib60","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1006\/nbdi.2001.0389","article-title":"Hypocretin levels in sporadic and familial cases of canine narcolepsy","volume":"8","author":"Ripley","year":"2001","journal-title":"Neurobiol Dis"},{"key":"10.1016\/S0140-6736(07)60237-2_bib61","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1073\/pnas.95.1.322","article-title":"The hypocretins: hypothalamus-specific peptides with neuroexcitatory activity","volume":"95","author":"de Lecea","year":"1998","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/S0140-6736(07)60237-2_bib62","doi-asserted-by":"crossref","first-page":"5675","DOI":"10.1111\/j.1742-4658.2005.04981.x","article-title":"The hypocretins and sleep","volume":"272","author":"De Lecea","year":"2005","journal-title":"FEBS J"},{"key":"10.1016\/S0140-6736(07)60237-2_bib63","doi-asserted-by":"crossref","first-page":"9996","DOI":"10.1523\/JNEUROSCI.18-23-09996.1998","article-title":"Neurons containing hypocretin (orexin) project to multiple neuronal systems","volume":"18","author":"Peyron","year":"1998","journal-title":"J Neurosci"},{"key":"10.1016\/S0140-6736(07)60237-2_bib64","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/S0092-8674(00)80949-6","article-title":"Orexins and orexin receptors: a family of hypothalamic neuropeptides and G protein-coupled receptors that regulate feeding behavior","volume":"92","author":"Sakurai","year":"1998","journal-title":"Cell"},{"key":"10.1016\/S0140-6736(07)60237-2_bib65","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1016\/S0896-6273(03)00330-1","article-title":"Distinct narcolepsy syndromes in Orexin receptor-2 and Orexin null mice: molecular genetic dissection of Non-REM and REM sleep regulatory processes","volume":"38","author":"Willie","year":"2003","journal-title":"Neuron"},{"key":"10.1016\/S0140-6736(07)60237-2_bib66","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/S0896-6273(01)00293-8","article-title":"Genetic ablation of orexin neurons in mice results in narcolepsy, hypophagia, and obesity","volume":"30","author":"Hara","year":"2001","journal-title":"Neuron"},{"key":"10.1016\/S0140-6736(07)60237-2_bib67","doi-asserted-by":"crossref","first-page":"4469","DOI":"10.1523\/JNEUROSCI.5560-03.2004","article-title":"Expression of a poly-glutamine-ataxin-3 transgene in orexin neurons induces narcolepsy-cataplexy in the rat","volume":"24","author":"Beuckmann","year":"2004","journal-title":"J Neurosci"},{"key":"10.1016\/S0140-6736(07)60237-2_bib68","doi-asserted-by":"crossref","first-page":"1893","DOI":"10.1212\/WNL.57.10.1893","article-title":"Polymorphisms in the vicinity of the hypocretin\/orexin are not associated with human narcolepsy","volume":"57","author":"Hungs","year":"2001","journal-title":"Neurology"},{"key":"10.1016\/S0140-6736(07)60237-2_bib69","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/S0140-6736(99)05582-8","article-title":"Hypocretin (orexin) deficiency in human narcolepsy","volume":"355","author":"Nishino","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/S0140-6736(07)60237-2_bib70","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1093\/sleep\/28.4.427","article-title":"Analysis of hypocretin (orexin) antibodies in patients with narcolepsy","volume":"28","author":"Black","year":"2005","journal-title":"Sleep"},{"key":"10.1016\/S0140-6736(07)60237-2_bib71","first-page":"1191","article-title":"HLA DQB1*0602 positive narcoleptic subjects with cataplexy have CSF lgG reactive to rat hypothalamic protein extract","volume":"28","author":"Black","year":"2005","journal-title":"Sleep"},{"key":"10.1016\/S0140-6736(07)60237-2_bib72","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.jneuroim.2006.02.010","article-title":"Immunohistochemical screening for autoantibodies against lateral hypothalamic neurons in human narcolepsy","volume":"174","author":"Overeem","year":"2006","journal-title":"J Neuroimmunol"},{"key":"10.1016\/S0140-6736(07)60237-2_bib73","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1002\/ana.1130","article-title":"Low cerebrospinal fluid hypocretin (Orexin) and altered energy homeostasis in human narcolepsy","volume":"50","author":"Nishino","year":"2001","journal-title":"Ann Neurol"},{"key":"10.1016\/S0140-6736(07)60237-2_bib74","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1212\/01.WNL.0000081049.14098.50","article-title":"CSF hypocretin levels in Guillain-Barre syndrome and other inflammatory neuropathies","volume":"61","author":"Nishino","year":"2003","journal-title":"Neurology"},{"key":"10.1016\/S0140-6736(07)60237-2_bib75","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/S1474-4422(05)70196-4","article-title":"Hypocretins (orexins) and sleep-wake disorders","volume":"4","author":"Baumann","year":"2005","journal-title":"Lancet Neurol"},{"key":"10.1016\/S0140-6736(07)60237-2_bib76","first-page":"254","article-title":"Discrimination of narcolepsy by using genetic markers and HLA","volume":"12","author":"Honda","year":"1983","journal-title":"Sleep Res"},{"key":"10.1016\/S0140-6736(07)60237-2_bib77","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/S0140-6736(85)92072-0","article-title":"Extraordinary association between HLA-DR2 and narcolepsy","volume":"1","author":"Billiard","year":"1985","journal-title":"Lancet"},{"key":"10.1016\/S0140-6736(07)60237-2_bib78","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1146\/annurev.genom.4.070802.110432","article-title":"The genetics of narcolepsy","volume":"4","author":"Chabas","year":"2003","journal-title":"Annu Rev Genomics Hum Genet"},{"key":"10.1016\/S0140-6736(07)60237-2_bib79","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1093\/sleep\/15.5.415","article-title":"DQB1-0602 (DQw1) is not present in most nonDR2 Caucasian narcoleptics","volume":"15","author":"Mignot","year":"1992","journal-title":"Sleep"},{"key":"10.1016\/S0140-6736(07)60237-2_bib80","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1111\/j.1399-0039.1998.tb02952.x","article-title":"HLA-DQB1*0602 homozygosity increases relative risk for narcolepsy but not disease severity in two ethnic groups","volume":"51","author":"Pelin","year":"1998","journal-title":"Tissue Antigens"},{"key":"10.1016\/S0140-6736(07)60237-2_bib81","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1086\/318799","article-title":"Complex HLA-DR and -DQ interactions confer risk of narcolepsy-cataplexy in three ethnic groups","volume":"68","author":"Mignot","year":"2001","journal-title":"Am J Hum Genet"},{"key":"10.1016\/S0140-6736(07)60237-2_bib82","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.1073\/pnas.0308458100","article-title":"Crystal structure of HLA-DQ0602 that protects against type 1 diabetes and confers strong susceptibility to narcolepsy","volume":"101","author":"Siebold","year":"2004","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/S0140-6736(07)60237-2_bib83","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/S1474-4422(02)00103-5","article-title":"The genetics of sleep disorders","volume":"1","author":"Taheri","year":"2002","journal-title":"Lancet Neurol"},{"key":"10.1016\/S0140-6736(07)60237-2_bib84","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1080\/07853890500372047","article-title":"Genes for normal sleep and sleep disorders","volume":"37","author":"Tafti","year":"2005","journal-title":"Ann Med"},{"key":"10.1016\/S0140-6736(07)60237-2_bib85","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1034\/j.1399-0039.1999.540204.x","article-title":"Significant association of a single nucleotide polymorphism in the tumor necrosis factor-alpha (TNF-alpha) gene promoter with human narcolepsy","volume":"54","author":"Hohjoh","year":"1999","journal-title":"Tissue Antigens"},{"key":"10.1016\/S0140-6736(07)60237-2_bib86","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1034\/j.1399-0039.2003.00068.x","article-title":"TNFA promoter polymorphisms and narcolepsy","volume":"61","author":"Wieczorek","year":"2003","journal-title":"Tissue Antigens"},{"key":"10.1016\/S0140-6736(07)60237-2_bib87","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1007\/s00109-002-0405-8","article-title":"Polymorphisms of the tumor necrosis factor receptors: no association with narcolepsy in German patients","volume":"81","author":"Wieczorek","year":"2003","journal-title":"J Mol Med"},{"key":"10.1016\/S0140-6736(07)60237-2_bib88","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1034\/j.1399-0039.2000.560508.x","article-title":"Significant association of the tumor necrosis factor receptor 2 (TNFR2) gene with human narcolepsy","volume":"56","author":"Hohjoh","year":"2000","journal-title":"Tissue Antigens"},{"key":"10.1016\/S0140-6736(07)60237-2_bib89","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/1471-2350-2-9","article-title":"ApoE polymorphisms in narcolepsy","volume":"2","author":"Gencik","year":"2001","journal-title":"BMC Med Genet"},{"key":"10.1016\/S0140-6736(07)60237-2_bib90","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1038\/sj.mp.4000911","article-title":"MAO-A and COMT polymorphisms and gene effects in narcolepsy","volume":"6","author":"Dauvilliers","year":"2001","journal-title":"Mol Psychiatry"},{"key":"10.1016\/S0140-6736(07)60237-2_bib91","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/S0140-6736(98)05831-0","article-title":"Analysis of the monoamine oxidase genes and the Norrie disease gene locus in narcolepsy","volume":"353","author":"Koch","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/S0140-6736(07)60237-2_bib92","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1038\/sj.tpj.6500088","article-title":"Sexual dimorphism of the catechol-O-methyltransferase gene in narcolepsy is associated with response to modafinil","volume":"2","author":"Dauvilliers","year":"2002","journal-title":"Pharmacogenomics J"},{"key":"10.1016\/S0140-6736(07)60237-2_bib93","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1007\/s00109-004-0569-5","article-title":"Screening for candidate gene regions in narcolepsy using a microsatellite based approach and pooled DNA","volume":"82","author":"Wieczorek","year":"2004","journal-title":"J Mol Med"},{"key":"10.1016\/S0140-6736(07)60237-2_bib94","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1016\/S0278-5846(01)00171-3","article-title":"Serotonergic polymorphisms in patients suffering from alcoholism, anxiety disorders and narcolepsy","volume":"25","author":"Fehr","year":"2001","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"issue":"suppl 1","key":"10.1016\/S0140-6736(07)60237-2_bib95","first-page":"S16","article-title":"Genetic and familial aspects of narcolepsy","volume":"50","author":"Mignot","year":"1998","journal-title":"Neurology"},{"issue":"suppl 8","key":"10.1016\/S0140-6736(07)60237-2_bib96","doi-asserted-by":"crossref","first-page":"S54","DOI":"10.1093\/sleep\/17.suppl_8.S54","article-title":"Family studies in narcolepsy","volume":"17","author":"Billiard","year":"1994","journal-title":"Sleep"},{"key":"10.1016\/S0140-6736(07)60237-2_bib97","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1006\/geno.2000.6143","article-title":"Linkage of human narcolepsy with HLA association to chromosome 4p13-q21","volume":"65","author":"Nakayama","year":"2000","journal-title":"Genomics"},{"key":"10.1016\/S0140-6736(07)60237-2_bib98","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1002\/ana.20208","article-title":"A narcolepsy susceptibility locus maps to a 5 Mb region of chromosome 21q","volume":"56","author":"Dauvilliers","year":"2004","journal-title":"Ann Neurol"},{"key":"10.1016\/S0140-6736(07)60237-2_bib99","doi-asserted-by":"crossref","first-page":"2137","DOI":"10.1212\/WNL.62.11.2137","article-title":"A monozygotic twin pair discordant for narcolepsy and CSF hypocretin-1","volume":"62","author":"Dauvilliers","year":"2004","journal-title":"Neurology"},{"key":"10.1016\/S0140-6736(07)60237-2_bib100","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1016\/S0140-6736(04)15951-5","article-title":"Monozygotic twins concordant for narcolepsy-cataplexy without any detectable abnormality in the hypocretin (orexin) pathway","volume":"363","author":"Khatami","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/S0140-6736(07)60237-2_bib101","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1093\/sleep\/26.6.663","article-title":"Month of birth as a risk factor for narcolepsy","volume":"26","author":"Dauvilliers","year":"2003","journal-title":"Sleep"},{"key":"10.1016\/S0140-6736(07)60237-2_bib102","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1093\/sleep\/27.8.1471","article-title":"The month-of-birth pattern in narcolepsy is moderated by cataplexy severity and may be independent of HLA-DQB1*0602","volume":"27","author":"Picchioni","year":"2004","journal-title":"Sleep"},{"key":"10.1016\/S0140-6736(07)60237-2_bib103","first-page":"122","article-title":"Modafinil: pharmacology and therapeutic perspectives","volume":"159","author":"Billiard","year":"2003","journal-title":"Rev Neurol (Paris)"},{"key":"10.1016\/S0140-6736(07)60237-2_bib104","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.smrv.2004.01.004","article-title":"Pharmacotherapy for cataplexy","volume":"8","author":"Houghton","year":"2004","journal-title":"Sleep Med Rev"},{"key":"10.1016\/S0140-6736(07)60237-2_bib105","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1093\/sleep\/29.7.939","article-title":"Sodium oxybate improves excessive daytime sleepiness in narcolepsy","volume":"29","author":"Black","year":"2006","journal-title":"Sleep"},{"key":"10.1016\/S0140-6736(07)60237-2_bib106","doi-asserted-by":"crossref","first-page":"14128","DOI":"10.1073\/pnas.93.24.14128","article-title":"Potential brain neuronal targets for amphetamine-, methylphenidate-, and modafinil-induced wakefulness, evidenced by c-fos immunocytochemistry in the cat","volume":"93","author":"Lin","year":"1996","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/S0140-6736(07)60237-2_bib107","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/0006-8993(92)91713-O","article-title":"Role of catecholamines in the modafinil and amphetamine induced wakefulness, a comparative pharmacological study in the cat","volume":"591","author":"Lin","year":"1992","journal-title":"Brain Res"},{"key":"10.1016\/S0140-6736(07)60237-2_bib108","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1093\/sleep\/17.5.436","article-title":"Modafinil binds to the dopamine uptake carrier site with low affinity","volume":"17","author":"Mignot","year":"1994","journal-title":"Sleep"},{"key":"10.1016\/S0140-6736(07)60237-2_bib109","first-page":"19","article-title":"Effect of the wake-promoting agent modafinil on sleep-promoting neurons from the ventrolateral preoptic nucleus: an in vitro pharmacologic study","volume":"27","author":"Gallopin","year":"2004","journal-title":"Sleep"},{"key":"10.1016\/S0140-6736(07)60237-2_bib110","first-page":"11","article-title":"Modafinil: a drug in search of a mechanism","volume":"27","author":"Saper","year":"2004","journal-title":"Sleep"},{"key":"10.1016\/S0140-6736(07)60237-2_bib111","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1016\/j.neuroscience.2005.02.003","article-title":"Dopaminergic-adrenergic interactions in the wake promoting mechanism of modafinil","volume":"132","author":"Wisor","year":"2005","journal-title":"Neuroscience"},{"key":"10.1016\/S0140-6736(07)60237-2_bib112","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1093\/sleep\/17.suppl_8.S107","article-title":"Modafinil: a double-blind multicentric study","volume":"17","author":"Billiard","year":"1994","journal-title":"Sleep"},{"key":"10.1016\/S0140-6736(07)60237-2_bib113","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1002\/ana.410430115","article-title":"Randomized trial of modafinil for the treatment of pathological somnolence in narcolepsy","volume":"43","year":"1998","journal-title":"Ann Neurol"},{"key":"10.1016\/S0140-6736(07)60237-2_bib114","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1212\/WNL.54.5.1166","article-title":"Randomized trial of modafinil as a treatment for the excessive daytime somnolence of narcolepsy","volume":"54","year":"2000","journal-title":"Neurology"},{"key":"10.1016\/S0140-6736(07)60237-2_bib115","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1093\/sleep\/9.1.260","article-title":"Treatment of narcolepsy: objective studies on methylphenidate, pemoline, and protriptyline","volume":"9","author":"Mitler","year":"1986","journal-title":"Sleep"},{"key":"10.1016\/S0140-6736(07)60237-2_bib116","doi-asserted-by":"crossref","first-page":"2051","DOI":"10.1001\/jama.1935.02760510023006","article-title":"The use of benzedrine for the treatment of narcolepsy","volume":"105","author":"Prinzmetal","year":"1935","journal-title":"JAMA"},{"key":"10.1016\/S0140-6736(07)60237-2_bib117","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1093\/sleep\/28.6.667","article-title":"Risks of high-dose stimulants in the treatment of disorders of excessive somnolence: a case-control study","volume":"28","author":"Auger","year":"2005","journal-title":"Sleep"},{"key":"10.1016\/S0140-6736(07)60237-2_bib118","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1016\/0140-6736(91)92966-6","article-title":"Mazindol in long-term treatment of narcolepsy","volume":"337","author":"Alvarez","year":"1991","journal-title":"Lancet"},{"key":"10.1016\/S0140-6736(07)60237-2_bib119","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1002\/j.1550-8528.1999.tb00414.x","article-title":"Serial echocardiographic and clinical evaluation of valvular regurgitation before, during, and after treatment with fenfluramine or dexfenfluramine and mazindol or phentermine","volume":"7","author":"Ryan","year":"1999","journal-title":"Obes Res"},{"key":"10.1016\/S0140-6736(07)60237-2_bib120","first-page":"429","article-title":"A long-term treatment of narcolepsy and excessive daytime sleepiness with pemoline (Bentanamin)","volume":"27","author":"Honda","year":"1980","journal-title":"Curr Ther Res"},{"key":"10.1016\/S0140-6736(07)60237-2_bib121","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1097\/00002826-199508000-00002","article-title":"Selegiline hydrochloride treatment in narcolepsy\u2014a double-blind placebo-controlled study","volume":"18","author":"Mayer","year":"1995","journal-title":"Clin Neuropharmacol"},{"key":"10.1016\/S0140-6736(07)60237-2_bib122","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1016\/S0140-6736(79)92495-4","article-title":"Clomipramine and and clonazepam in narcolepsy","volume":"2","author":"Parkes","year":"1979","journal-title":"Lancet"},{"key":"10.1016\/S0140-6736(07)60237-2_bib123","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1093\/sleep\/9.2.371","article-title":"Fluoxetine in the treatment of cataplexy","volume":"9","author":"Langdon","year":"1986","journal-title":"Sleep"},{"key":"10.1016\/S0140-6736(07)60237-2_bib124","first-page":"217","article-title":"Venlafaxine in the treatment of the narcoleptic syndrome","volume":"5","author":"Smith","year":"1996","journal-title":"J Sleep Res"},{"key":"10.1016\/S0140-6736(07)60237-2_bib125","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1517\/14728214.9.2.281","article-title":"Emerging drugs for narcolepsy","volume":"9","author":"Abad","year":"2004","journal-title":"Expert Opin Emerg Drugs"},{"key":"10.1016\/S0140-6736(07)60237-2_bib126","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1093\/sleep\/28.6.754","article-title":"Emerging therapies in narcolepsy-cataplexy","volume":"28","author":"Mignot","year":"2005","journal-title":"Sleep"},{"key":"10.1016\/S0140-6736(07)60237-2_bib127","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1093\/sleep\/9.1.265","article-title":"Therapeutic effects of mazindol on narcolepsy","volume":"9","author":"Iijima","year":"1986","journal-title":"Sleep"},{"key":"10.1016\/S0140-6736(07)60237-2_bib128","first-page":"42","article-title":"A randomized, double blind, placebo-controlled multicenter trial comparing the effects of three doses of orally administered sodium oxybate with placebo for the treatment of narcolepsy","volume":"25","year":"2002","journal-title":"Sleep"},{"key":"10.1016\/S0140-6736(07)60237-2_bib129","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/S0301-0082(96)00064-0","article-title":"The gamma-hydroxybutyrate signalling system in brain: organisation and functional implications","volume":"51","author":"Maitre","year":"1997","journal-title":"Progr Neurobiol"},{"key":"10.1016\/S0140-6736(07)60237-2_bib130","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1093\/sleep\/16.3.216","article-title":"Gammahydroxybutyrate and narcolepsy: a double-blind placebo-controlled study","volume":"16","author":"Lammers","year":"1993","journal-title":"Sleep"},{"key":"10.1016\/S0140-6736(07)60237-2_bib131","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.sleep.2003.11.002","article-title":"Sodium oxybate demonstrates long-term efficacy for the treatment of cataplexy in patients with narcolepsy","volume":"5","year":"2004","journal-title":"Sleep Med"},{"key":"10.1016\/S0140-6736(07)60237-2_bib132","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1093\/brain\/awl079","article-title":"Correlates of sleep-onset REM periods during the Multiple Sleep Latency Test in community adults","volume":"129","author":"Mignot","year":"2006","journal-title":"Brain"},{"key":"10.1016\/S0140-6736(07)60237-2_bib133","doi-asserted-by":"crossref","first-page":"4649","DOI":"10.1073\/pnas.0400590101","article-title":"Orexin peptides prevent cataplexy and improve wakefulness in an orexin neuron-ablated model of narcolepsy in mice","volume":"101","author":"Mieda","year":"2004","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/S0140-6736(07)60237-2_bib134","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1046\/j.1365-2869.2003.00380.x","article-title":"Clinical efficacy of high-dose intravenous immunoglobulins near the onset of narcolepsy in a 10\u2013year-old boy","volume":"12","author":"Lecendreux","year":"2003","journal-title":"J Sleep Res"},{"key":"10.1016\/S0140-6736(07)60237-2_bib135","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1002\/ana.20339","article-title":"Successful management of cataplexy with intravenous immunoglobulins at narcolepsy onset","volume":"56","author":"Dauvilliers","year":"2004","journal-title":"Ann Neurol"},{"key":"10.1016\/S0140-6736(07)60237-2_bib136","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1002\/ana.20603","article-title":"Late-onset narcolepsy presenting as rapidly progressing muscle weakness: response to plasmapheresis","volume":"58","author":"Chen","year":"2005","journal-title":"Ann Neurol"}],"container-title":["The Lancet"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0140673607602372?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0140673607602372?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T13:49:17Z","timestamp":1794318557000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0140673607602372"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,2]]},"references-count":136,"journal-issue":{"issue":"9560","published-print":{"date-parts":[[2007,2]]}},"alternative-id":["S0140673607602372"],"URL":"https:\/\/doi.org\/10.1016\/s0140-6736(07)60237-2","relation":{},"ISSN":["0140-6736"],"issn-type":[{"value":"0140-6736","type":"print"}],"subject":[],"published":{"date-parts":[[2007,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Narcolepsy with cataplexy","name":"articletitle","label":"Article Title"},{"value":"The Lancet","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S0140-6736(07)60237-2","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2007 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}